Trace Matters is a technology startup with the slogan "Powering mass spectrometry measurements at its best." Established in 2013 and headquartered in the United States, the company focuses on developing advanced mass spectrometry technologies for a wide range of demanding applications within the Biotechnology sector. This includes innovative mass spectrometry hardware, methods, and applications to address the most rigorous analysis needs across industries. The latest investment of $350.00K grant was secured by Trace Matters on 01 January 2022, with the notable investor being NASA. This financing is anticipated to support the company's continued growth and the development of cutting-edge solutions in mass spectrometry. With its innovative approach to mass spectrometry, Trace Matters is poised to make significant advancements in this critical field.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | $350.00K | 1 | 01 Jan 2022 | |
Grant | $65.00K | 1 | National Institutes of Health | 01 Jan 2021 |
Grant | $100.00K | 1 | 08 Dec 2020 | |
Grant | $150.00K | 1 | 01 Aug 2019 | |
Grant | $330.00K | 1 | 01 Aug 2018 |
No recent news or press coverage available for Trace Matters.